Global epidemiology of cirrhosis - aetiology, trends and predictions

被引:403
作者
Huang, Daniel Q. [1 ,2 ,3 ]
Terrault, Norah A. [4 ]
Tacke, Frank [5 ,6 ]
Gluud, Lise Lotte [7 ,8 ]
Arrese, Marco [9 ,10 ]
Bugianesi, Elisabetta [11 ]
Loomba, Rohit [1 ,12 ]
机构
[1] Univ Calif San Diego, NAFLD Res Ctr, Div Gastroenterol, San Diego, CA 92093 USA
[2] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore
[3] Natl Univ Hlth Syst, Dept Med, Div Gastroenterol & Hepatol, Singapore, Singapore
[4] Univ Southern Calif, Div Gastrointestinal & Liver Dis, Los Angeles, CA USA
[5] Charite Univ Med Berlin, Dept Hepatol & Gastroenterol, Campus Virchow Klinikum, Berlin, Germany
[6] Charite Univ Med Berlin, Campus Charite Mitte, Berlin, Germany
[7] Copenhagen Univ Hosp, Gastro Unit, Hvidovre, Denmark
[8] Univ Copenhagen, Fac Hlth Sci, Dept Clin Med, Copenhagen, Denmark
[9] Pontificia Univ Catolica Chile, Escuela Med, Dept Gastroenterol, Santiago, Chile
[10] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Envejecimiento & Regenerac CARE, Santiago, Chile
[11] Univ Turin, Dept Med Sci, Div Gastroenterol & Hepatol, Turin, Italy
[12] Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Epidemiol, San Diego, CA 92093 USA
关键词
FATTY LIVER-DISEASE; HEPATITIS-B; NONALCOHOLIC STEATOHEPATITIS; HEPATOCELLULAR-CARCINOMA; DECOMPENSATED CIRRHOSIS; NATURAL-HISTORY; BURDEN; PREVALENCE; MANAGEMENT; ALCOHOL;
D O I
10.1038/s41575-023-00759-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cirrhosis is an important cause of morbidity and mortality in people with chronic liver disease worldwide. In 2019, cirrhosis was associated with 2.4% of global deaths. Owing to the rising prevalence of obesity and increased alcohol consumption on the one hand, and improvements in the management of hepatitis B virus and hepatitis C virus infections on the other, the epidemiology and burden of cirrhosis are changing. In this Review, we highlight global trends in the epidemiology of cirrhosis, discuss the contributions of various aetiologies of liver disease, examine projections for the burden of cirrhosis, and suggest future directions to tackle this condition. Although viral hepatitis remains the leading cause of cirrhosis worldwide, the prevalence of non-alcoholic fatty liver disease (NAFLD) and alcohol-associated cirrhosis are rising in several regions of the world. The global number of deaths from cirrhosis increased between 2012 and 2017, but age-standardized death rates (ASDRs) declined. However, the ASDR for NAFLD-associated cirrhosis increased over this period, whereas ASDRs for other aetiologies of cirrhosis declined. The number of deaths from cirrhosis is projected to increase in the next decade. For these reasons, greater efforts are required to facilitate primary prevention, early detection and treatment of liver disease, and to improve access to care. In this Review, Huang et al. highlight global trends in the epidemiology of cirrhosis, including contributions of various aetiologies of liver disease, and consider what needs to be done to address projected increases in the burden of cirrhosis.
引用
收藏
页码:388 / 398
页数:11
相关论文
共 132 条
[11]   Acute-on-chronic liver failure in cirrhosis [J].
Arroyo, Vicente ;
Moreau, Richard ;
Kamath, Patrick S. ;
Jalan, Rajiv ;
Gines, Pere ;
Nevens, Frederik ;
Fernandez, Javier ;
To, Uyen ;
Garcia-Tsao, Guadalupe ;
Schnabl, Bernd .
NATURE REVIEWS DISEASE PRIMERS, 2016, 2 :1-18
[12]   Burden of liver diseases in the world [J].
Asrani, Sumeet K. ;
Devarbhavi, Harshad ;
Eaton, John ;
Kamath, Patrick S. .
JOURNAL OF HEPATOLOGY, 2019, 70 (01) :151-171
[13]   Validity of administrative codes associated with cirrhosis in Sweden [J].
Bengtsson, Bonnie ;
Askling, Johan ;
Ludvigsson, Jonas F. ;
Hagstrom, Hannes .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (10) :1205-1210
[14]   Trends in Liver Transplantation for Acute Alcohol-Associated Hepatitis During the COVID-19 Pandemic in the US [J].
Bittermann, Therese ;
Mahmud, Nadim ;
Abt, Peter .
JAMA NETWORK OPEN, 2021, 4 (07)
[15]   Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study [J].
Blach, Sarah ;
Terrault, Norah A. ;
Tacke, Frank ;
Gamkrelidze, Ivane ;
Craxi, Antonio ;
Tanaka, Junko ;
Waked, Imam ;
Dore, Gregory J. ;
Abbas, Zaigham ;
Abdallah, Ayat R. ;
Abdulla, Maheeba ;
Aghemo, Alessio ;
Aho, Inka ;
Akarca, Ulus S. ;
Alalwan, Abduljaleel M. ;
Blome, Marianne Alanko ;
Al-Busafi, Said A. ;
Aleman, Soo ;
Alghamdi, Abdullah S. ;
Al-Hamoudi, Waleed K. ;
Aljumah, Abdulrahman A. ;
Al-Naamani, Khalid ;
Al Serkal, Yousif M. ;
Altraif, Ibrahim H. ;
Anand, Anil C. ;
Anderson, Motswedi ;
Andersson, Monique, I ;
Athanasakis, Kostas ;
Baatarkhuu, Oidov ;
Bakieva, Shokhista R. ;
Ben-Ari, Ziv ;
Bessone, Fernando ;
Biondi, Mia J. ;
Bizri, Abdul Rahman N. ;
Mello, Carlos E. Brandaoo ;
Brigida, Krestina ;
Brown, Kimberly A. ;
Brown, Robert S., Jr. ;
Bruggmann, Philip ;
Brunetto, Maurizia R. ;
Busschots, Dana ;
Buti, Maria ;
Butsashvili, Maia ;
Cabezas, Joaquin ;
Chae, Chungman ;
Ivanova, Viktorija Chaloska ;
Chan, Henry Lik Yuen ;
Cheinquer, Hugo ;
Cheng, Kent Jason ;
Cheon, Myeong Eun .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (05) :396-415
[16]   Impact of COVID-19 on global HCV elimination efforts [J].
Blach, Sarah ;
Kondili, Loreta A. ;
Aghemo, Alessio ;
Cai, Zongzhen ;
Dugan, Ellen ;
Estes, Chris ;
Gamkrelidze, Ivane ;
Ma, Siya ;
Pawlotsky, Jean-Michel ;
Razavi-Shearer, Devin ;
Razavi, Homie ;
Waked, Imam ;
Zeuzem, Stefan ;
Craxi, Antonio .
JOURNAL OF HEPATOLOGY, 2021, 74 (01) :31-36
[17]   Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B [J].
Chang, Ting-Tsung ;
Liaw, Yun-Fan ;
Wu, Shun-Sheng ;
Schiff, Eugene ;
Han, Kwang-Hyub ;
Lai, Ching-Lung ;
Safadi, Rifaat ;
Lee, Samuel S. ;
Halota, Waldemar ;
Goodman, Zachary ;
Chi, Yun-Chan ;
Zhang, Hui ;
Hindes, Robert ;
Iloeje, Uchenna ;
Beebe, Suzanne ;
Kreter, Bruce .
HEPATOLOGY, 2010, 52 (03) :886-893
[18]  
Charatcharoenwitthaya Phunchai, 2020, Clin Liver Dis (Hoboken), V16, P231, DOI 10.1002/cld.920
[19]   Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience [J].
Chen, V. L. ;
Yeh, M. -L. ;
Le, A. K. ;
Jun, M. ;
Saeed, W. K. ;
Yang, J. D. ;
Huang, C. -F. ;
Lee, H. Y. ;
Tsai, P. -C. ;
Lee, M. -H. ;
Giama, N. ;
Kim, N. G. ;
Nguyen, P. P. ;
Dang, H. ;
Ali, H. A. ;
Zhang, N. ;
Huang, J. -F. ;
Dai, C. -Y. ;
Chuang, W. -L. ;
Roberts, L. R. ;
Jun, D. W. ;
Lim, Y. -S. ;
Yu, M. -L. ;
Nguyen, M. H. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (01) :44-54
[20]   Progress towards elimination goals for viral hepatitis [J].
Cox, Andrea L. ;
El-Sayed, Manal H. ;
Kao, Jia-Horng ;
Lazarus, Jeffrey V. ;
Lemoine, Maud ;
Lok, Anna S. ;
Zoulim, Fabien .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (09) :533-542